CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 145 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 1.85 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $334,220 | +23.4% | 20,158 | +38.4% | 0.02% | +11.1% |
| Q4 2022 | $270,835 | -10.3% | 14,561 | -38.0% | 0.02% | -10.0% |
| Q3 2022 | $302,000 | -60.0% | 23,504 | -83.5% | 0.02% | -52.4% |
| Q3 2021 | $755,000 | -4.3% | 142,529 | +3.9% | 0.04% | 0.0% |
| Q2 2021 | $789,000 | +39.9% | 137,216 | +12.1% | 0.04% | +31.2% |
| Q1 2021 | $564,000 | +96.5% | 122,419 | +42.6% | 0.03% | +52.4% |
| Q4 2020 | $287,000 | +63.1% | 85,874 | +45.0% | 0.02% | +250.0% |
| Q3 2020 | $176,000 | +175.0% | 59,234 | +375.6% | 0.01% | +500.0% |
| Q1 2019 | $64,000 | – | 12,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 208,189 | $1,726,000 | 3.48% |
| FRIESS ASSOCIATES LLC | 571,940 | $4,741,000 | 2.53% |
| GABLES CAPITAL MANAGEMENT INC. | 438,764 | $3,637,000 | 2.28% |
| Prairiewood Capital, LLC | 258,073 | $2,139,000 | 1.50% |
| Quantedge Capital Pte Ltd | 597,300 | $4,952,000 | 1.46% |
| ARMISTICE CAPITAL, LLC | 8,372,000 | $69,404,000 | 1.34% |
| SummerHaven Investment Management, LLC | 158,473 | $1,314,000 | 0.74% |
| Capital Impact Advisors, LLC | 99,322 | $823,000 | 0.60% |
| EAM Investors, LLC | 365,415 | $3,029,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 304,515 | $2,524,000 | 0.51% |